Back

Frailty and bleeding events in patients with heart failure: Insights from the JROADHF-NEXT

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Interplay of frailty, sarcopenia, depression, and cardio-oncology in heart failure outcomes Comorbidities HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Taisuke Nakade

Juntendo University Graduate School of Medicine, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
Impact of sarcopenia and dynapenia on the prognosis of right heart failure
Doctor C. Chavez Guzman (Mexico City, MX)
Abstract Slides Video
Presentation thumbnail
The role of cystatin c-creatinine eGFR difference in assessing renal function and its correlation with frailty in patients with worsening heart failure: a real-world study
Doctor C. Fumagalli (Varese, IT)
Abstract Slides Video
Presentation thumbnail
Specific antidepressant effects among heart failure patients with depression: real life data
Professor M. Yilmaz (Izmir, TR)
Abstract Slides Video
Presentation thumbnail
The reverse cardio-oncology perspective: the incidence of, and mortality from, cancer subsequent to a diagnosis of heart failure; an updated review and meta-analysis of observational studies.
Doctor L. Sanasi (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Prevalence of diagnosed heart failure in 12 million patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Mr U. Razzaq (Glasgow, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Interplay of frailty, sarcopenia, depression, and cardio-oncology in heart failure outcomes

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Direct oral anticoagulants in patients with heart failure and atrial fibrillation: do we have an ideal score to predict major bleeding?
thumbnail
Congress Presentation
The impact of age, disease progression, depression, and hospitalization duration on frailty in patients with heart failure
thumbnail
Congress Presentation
Frailty and cardiovascular comorbidities as predictors of short-term outcomes in HFpEF and HFmrEF patients: a retrospective cohort analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources